1Department of Pharmacology, College of Medicine, Catholic University, Seoul 137-701; 2Department of Neuroscience, School of Medicine, Ewha Institute for Neuroscience, Ewha Women's University, Seoul 110-783, Korea; and 3Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee 37232
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Sung, Ki-Wug,
Sukwoo Choi, and
David M. Lovinger.
Activation of Group I mGluRs Is Necessary for Induction of
Long-Term Depression at Striatal Synapses.
J. Neurophysiol. 86: 2405-2412, 2001.
Activation of metabotropic
glutamate receptors (mGluRs), which are coupled to G proteins, has
important roles in certain forms of synaptic plasticity including
corticostriatal long-term depression (LTD). In the present study,
extracellular field potential and whole cell voltage-clamp recording
techniques were used to investigate the effect of mGluR antagonists
with different subtype specificity on high-frequency stimulation
(HFS)-induced LTD of synaptic transmission in the striatum of brain
slices obtained from 15-to 25-day-old rats. Induction of LTD was
prevented during exposure to the nonselective mGluR antagonist
(RS)--methyl-4-carboxyphenylglycine (500 µM). The group I
mGluR-selective antagonists (S)-4-carboxy-phenylglycine (50 µM) and (RS)-1-aminoindan-1,5-dicarboxylic acid (100 µM) prevented induction of LTD when applied before and during HFS. The
mGluR1-selective antagonist 7-(Hydroxyimino)
cyclopropa[b]chromen-1a-carboxylate ethyl ester (80 µM) also
blocked LTD induction. Unexpectedly, the mGluR5-selective antagonist
2-methyl-6-(phenylethyl)-pyridine (10 µM) also prevented LTD
induction. The group II mGluR antagonist LY307452 (10 µM) did not
block LTD induction at corticostriatal synapses, but LY307452 was able
to block transient synaptic depression induced by the group II agonist
LY314593. None of the antagonists had any effect on basal synaptic
transmission at the concentrations used, and mGluR antagonists did not
reverse LTD when applied beginning 20 min after HFS. These results
suggest that both group I mGluR subtypes contribute to the induction of
LTD at corticostriatal synapses.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The neostriatum (caudate and
putamen) is involved in the control of movement (Alexander et
al. 1986; Chevalier and Deniau 1990
;
Graybiel et al. 1994
; Groves 1983
), and
it appears that certain forms of learning and memory involve changes in
neostriatal function (Jog et al. 1999
; Whishaw
and Kolb 1984
). The major excitatory input to the neostriatum
arises from neurons in the neocortex that use glutamate as a
neurotransmitter (Graybiel 1990
; Parent 1990
). Synaptic transmission at corticostriatal synapses is
mediated by AMPA receptors with very little involvement of
N-methyl-D-aspartate (NMDA) receptors
(Cherubini et al. 1988
; Herrling
1985
; Lovinger et al. 1993a
). Repetitive
activation of corticostriatal glutamatergic synapses produces
activity-dependent changes in synaptic efficacy. One such form of
synaptic plasticity is long-term depression (LTD) of excitatory
synaptic transmission in the striatum. This change in synaptic efficacy
has been observed both in vivo (Garcia-Munoz et al.
1996
) and in vitro (Calabresi et al. 1992
;
Lovinger et al. 1993b
; Walsh 1993
).
Synaptic plasticity in the striatum may contribute to long-term
behavioral changes, such as those induced by motor learning during
neural development, antipsychotic agents, or neurodegenerative diseases
including Parkinson's disease and Huntington's disease.
Corticostriatal LTD has been shown to be dependent on activation of
certain forms of calcium channels (Calabresi et al.
1992
; Choi and Lovinger 1997a
) as well as
dopamine receptors and metabotropic glutamate receptors
(Calabresi et al. 1992
). However, it is not clear
what metabotropic glutamate receptor (mGluR) subtypes participate in
LTD induction.
In the striatum, group I mGluRs are particularly highly expressed in
the spines and dendrites of medium spiny neurons (Testa et al.
1998). Glutamate can stimulate phosphoinositide (PI) hydrolysis leading to increases in intracellular calcium concentration in striatal
neurons through group I mGluR actions (Casabona et al. 1997
). This signaling mechanism is one of the essential
conditions for corticostriatal LTD induction (Calabresi et al.
1994
; Choi and Lovinger 1997a
,b
).
Calabresi et al. (1992)
reported that activation of
mGluRs is required for the induction of corticostriatal LTD because
this induction can be blocked by the mGluR antagonist, 2-amino-3-phosphonopropionic acid (AP3). AP3 is a rather nonselective, low-affinity antagonist for mGluRs, although it has higher affinity for
group I mGluRs than for the other receptor subtypes (Saugstad et
al. 1995
). Thus there is some evidence that group I mGluRs may
be involved in LTD induction, but this hypothesis has not been tested
with the newer, more potent and selective group I mGluR antagonists.
Furthermore, the effect of the mGluR1 and 5 subtype selective
antagonists 7-(Hydroxyimino) cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPPCOOEt) and 2-methyl-6-(phenylethyl)-pyridine (MPEP) on
striatal LTD has not been examined. In the present study, we tested
whether glutamate acting via group I mGluRs might be important for the
induction of corticostriatal LTD using selective group I and II mGluRs antagonists.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Brain slices were prepared from 15- to 25-day-old Sprague-Dawley
rats using previously described techniques (Tang and Lovinger 2000). Rats were killed by decapitation, and the brains were
removed and placed in ice-cold, modified artificial cerebrospinal fluid (ACSF) containing (in mM) 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 D-glucose adjusted to pH 7.4 by bubbling with 95%
O2-5% CO2. Coronal slices
(400 µm thick) were cut using a manual vibroslice (Campden
Instruments, Cambridge, UK). Brain slices were transferred to ACSF
containing (in mM) 124 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 D-glucose adjusted to pH 7.4 by bubbling with 95%
O2-5% CO2 at room
temperature. Slices were used for electrophysiological experiments
beginning 1 h after the end of slice preparation. A hemislice
containing the cortex and striatum just anterior to the globus pallidus
was completely submerged in a recording chamber and continuously
superfused (at a flow rate of 2-3 ml/min) with ACSF that was
constantly bubbled with 95% O2-5%
CO2. The temperature of the bath solution was
kept at 30-32°C.
Extracellular field potential recordings were performed in the lateral
half of the dorsal striatum to record population spikes (PSs) evoked by
stimulation of excitatory afferents. Stimuli were delivered by an S88
stimulator and a PSIU6 optical isolation unit (Grass Instruments,
Quincy, MA) through a bipolar, Teflon-coated tungsten electrode placed
in the white matter dorsal to the striatum. PSs were recorded with a
glass micropipette (<1 M tip resistance) filled with 0.9% saline,
placed at a site 1-2 mm ventral to the stimulating electrode. The
position of the recording electrode was optimized by recording
responses to low frequency stimulation (0.02-0.2 ms, 0.5-1.5 mA at
0.1 Hz), and the electrode was set at the depth where the maximal PS
amplitude was observed. Stimulus intensity was then adjusted to evoke a
PS with amplitude approximately half of the maximum. Once a PS of
half-maximal amplitude triggered by 0.05-Hz stimuli had been stably
maintained for 10-15 min, receptor agonists or antagonists were
delivered, and/or high-frequency stimulation (HFS) was applied. HFS
consisted of four 100-Hz trains of 1 s duration delivered at a
frequency of one train every 10 s. During HFS, the stimulus
intensity was increased to the level producing a maximal PS response.
Field potentials were amplified 1,000 times, using a differential AC
amplifier (A-M systems, Olympia, WA), and low-pass filtered at 5 kHz.
Amplified signals were digitized using a TL-1-125 interface (Axon
Instruments, Foster City, CA) or CED 1401 plus interface (Cambridge
Electronic Design, Cambridge, UK) and stored on a computer using
pClamp6.0 (Axon Instruments) or WCP software (Strathclyde
Electrophysiology Software, version 3.1.4, Glasgow, UK).
Whole cell voltage-clamp recordings were performed to record the
stimulus-induced excitatory postsynaptic currents (EPSCs) at
glutamatergic striatal synapses. Slices were placed in the recording
chamber and superfused with ACSF as described in the preceding text.
Tight-seal whole cell recordings were obtained using pipettes made from
borosilicate glass capillaries pulled on a Flaming-Brown micropipette
puller (Sutter Instruments, Novato, CA). Pipette resistance ranged from
2.5 to 3 M, when filled with internal solution containing (in mM)
120 CsMeSO3, 5 NaCl, 10 tetraethylammonium chloride, 10 HEPES, 5 lidocaine N-ethyl bromide (QX-314)
(Br2+ salt), 1.1 EGTA, 4 ATP
(Mg2+ salt), and 0.3 GTP
(Na+ salt), pH adjusted to 7.2 with CsOH,
osmolarity adjusted to 290-300 mOsm with sucrose. Recordings from
medium-sized neurons within two or three layers below the surface of
slices were made under differential interference contrast-enhanced
visual guidance.
Neurons were voltage-clamped at 60 or
70 mV during the whole cell
recording period before and after application of HFS. Stimuli were
delivered to the white matter dorsal to the striatum as described for
field potential recordings. The series resistance, which was not
compensated and was typically between 5 and 10 M
, was monitored
during the recording. Once a stable EPSC of 100-300 pA amplitude
triggered by 0.05-Hz stimuli had been recorded for 10-15 min, drugs
were delivered and/or LTD induction was attempted by pairing HFS and
depolarization. HFS consisted of four 100-Hz trains of 1 s
duration delivered at a frequency of one train every 10 s, with
simultaneous 1-s depolarization of postsynaptic neurons to
10 or 0 mV. Whole cell currents recorded with an Axopatch 1D amplifier (Axon
Instruments) were filtered at 5 kHz, digitized at
20 kHz using a
DigiData 1200 interface (Axon Instruments) and stored on computer using
pClamp 6.0 software (Axon Instruments). Changes in PS and EPSC
amplitude after HFS or drug treatment are expressed as the percentage
of the baseline response. The magnitude of LTD was defined as the ratio
of the average PS amplitude 20-30 min (30 episodes) following HFS to
the average response amplitude during a 10-min baseline pre-HFS
recording period (30 episodes) in all experiments. The representative
PS and EPSC waveforms shown in the text are the average of 15-30
consecutive individual responses during a given recording. LTD was
defined as a decrease in the amplitude of PS or EPSC after HFS of >2
SDs below the baseline PS. All averaged values are presented as
means ± SE. The statistical significance of changes in synaptic
responses relative to baseline response amplitude was determined using
a two-tailed paired t-test. The statistical criterion for
significance was P < 0.05.
(RS)-1-Aminoindan-1,5-dicarboxylic acid (AIDA),
(S)-4-carboxyphenylglycine (4-CPG), CPCCOEt,
(RS)-3,5-dihydroxyphenylglycine (DHPG),
(RS)--methyl-4-carboxyphenylglycine (MCPG), and MPEP were purchased
from Tocris Cookson (Ballwin, MO). LY307452 and LY314593 were obtained
as a gift from Dr. D. D. Shoepp (Lilly Research Laboratories). All
other chemicals used in this experiment were ACS grade and purchased
from Sigma (St. Louis, MO). Drugs tested in slice experiments were
diluted with ACSF immediately before use from stock solutions prepared
according to the manufacturers' instructions. Drug solutions were
delivered into the recording chamber by gravity flow.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
As a control experiment to determine the frequency of LTD induction at excitatory synapses in dorsolateral striatum, we examined the induction rate of LTD in 36 hemislices from 18 coronal slices at the same range of anterior-posterior positions. We found that 52% of the hemislices tested showed long-lasting decreases in PS amplitude (as defined in METHODS), 31% exhibited no change (PSs changed <20%), and 17% showed long-term potentiation (LTP, increase in PS amplitude of >20% of baseline 20 min after HFS). When one hemislice showed LTD in response to HFS, application of the same HFS protocol in the other hemislice from the same coronal brain slice resulted in LTD in 78% of the paired slices, no change in 11% of the slices, and LTP in 11% of the slice. Because of the high concordance of paired hemislices with respect to LTD expression, we tested mGluR antagonist effects on LTD induction using hemislices in which the paired control hemislice had been shown to express LTD when HFS was given in the absence of antagonist.
The nonselective mGluR antagonist MCPG (500 µM) prevented LTD when applied before and during HFS. Field potential recordings revealed that HFS failed to induce LTD (108.8 ± 6.8% of baseline PS amplitude) in the presence of MCPG. After HFS in MCPG, we removed the antagonist from the bath and delivered a second set of HFS stimuli. In four of the six slices examined, we observed a decrease in PS amplitude of >20% (59.5 ± 0.7% of baseline PS) after removal of MCPG. In slices that were not exposed to MCPG, the PS amplitude decreased to 58.4 ± 9.2% of baseline PS following HFS. This finding supported earlier studies indicating the necessity for activation of an mGluR in the induction of striatal LTD but did not clarify which mGluR was involved.
To determine the mGluR subtype(s) involved in LTD induction, we
examined the effect of group I and II selective mGluR antagonists on
striatal LTD induction in 35 paired hemislices from 32 animals. We
applied each antagonist for a total of 10 min, 5 min prior to HFS, and
an additional 5 min during and after HFS. The effects of the group I
mGluR antagonists 4-CPG, AIDA, MPEP, and CPCCOEt were examined first.
Pretreatment with the group I mGluR antagonist 4-CPG (50 µM)
prevented the induction LTD by HFS (Fig.
1A, 3.2 ± 11.1%
decrease in PS amplitude relative to baseline, P = 0.66 paired t-test, n = 8). Application of 4-CPG
(50 µM) did not alter the PS amplitude during the recording period
prior to HFS (Fig. 1, A and B). HFS resulted in a
long-lasting decrease in PS amplitude in paired control hemislices
(37.8 ± 6.7% decrease in PS amplitude, P < 0.001, paired t-test, n = 8). The effect of
4-CPG on LTD induction was also examined using whole cell recording. In
the absence of antagonist, HFS induced a long-lasting decrease of
39.7 ± 8.3% in EPSC amplitude (P < 0.05, paired
t-test, n = 5), but HFS did not alter EPSC
amplitude in the presence of 50 µM 4-CPG (amplitude decreased by
3.7 ± 13.6%, P = 0.9429, paired
t-test, n = 5; Fig. 1B).
|
We also examined the effect of other group I mGluR selective antagonists on induction of corticostriatal LTD in field potential recording experiments. AIDA prevented depression of PSs by HFS. LTD could be induced in control slices (41.1 ± 6.8% decrease in PS amplitude, P < 0.05, paired t-test, n = 5) but not in the presence of AIDA (100 µM, 14.15 ± 12% decrease in PS amplitude, P = 0.3083, paired t-test, n = 5, Fig. 2). The recently developed antagonists CPCCOEt and MPEP have been shown to selectively block activation of mGluRs1 and 5, respectively. We thus examined the effect of these compounds on induction of striatal LTD to determine which of these group I mGluRs was involved in this form of synaptic plasticity. Pretreatment with CPCCOEt (80 µM) blocked the induction of corticostriatal LTD by HFS (4.5 ± 6.4% decrease in PS amplitude, P = 0.3663, paired t-test, n = 5) when compared with control slices (36.6 ± 4.1% decrease in PS amplitude, P < 0.01, paired t-test, n = 5, Fig. 3A). Pretreatment with MPEP (10 µM) also prevented induction of LTD by HFS. Indeed, when HFS was delivered in the presence of MPEP, we observed an increase of >20% in PS amplitude in three of six tested slices. The remainder of the MPEP-treated slices showed no LTD induction. The average change in amplitude after PS was not statistically significant (42.9 ± 24.9% increase in PS amplitude, P = 0.1454, paired t-test, n = 6). In control slices, LTD could be induced by HFS (44.4 ± 7.6% decrease in PS amplitude, P < 0.005, paired t-test, n = 6, Fig. 3B).
|
|
The findings reported in the preceding text suggested involvement of
group I mGluRs in induction of striatal LTD. However, it is also
possible that group II receptors participate in synaptic plasticity,
and it is known that this class of mGluRs can influence transmission at
glutamatergic striatal synapses (Lovinger and McCool
1995). We thus examined the effect of a group II mGluR selective antagonist LY307452 on LTD induction. This antagonist did not
block LTD induction. In slices pretreated with LY307452 (10 µM), LTD
could be induced by HFS (34.6 ± 12.9% decrease in PS amplitude,
P < 0.05, paired t-test, n = 5, Fig. 4A). To ensure that
the LY307452 was active in our striatal slice preparation, we examined
the ability of this compound to antagonize synaptic depression produced
by acute exposure to a group II mGluR agonist. Previously we have shown
that mGluR2,3-selective agonists inhibit the synaptically driven PS
evoked by afferent stimulation during field potential recording in
striatal slices (Lovinger and McCool 1995
). In agreement
with this result, we observed that the group II mGluR selective agonist
LY314593 (10 µM) inhibited the PS evoked by afferent stimulation in
striatal slices (n = 3). As expected, LY307452 (7 µM)
completely reversed the synaptic depressant actions of LY314593 (Fig.
4B). The group I mGluR agonist DHPG (100 µM) did not alter
PSs evoked by low-frequency stimuli as we have previously observed
(data not shown).
|
Synaptic responses produced by low-frequency afferent stimulation were not altered by either group I or group II mGluR antagonists (as can be seen in Figs. 1-3 during the pre-HFS drug application period). We measured PS amplitude in response to low-frequency stimulation in the presence and absence of each of the mGluR antagonists before HFS, and the amplitude was not significantly altered by any of the antagonists (paired t-test, P > 0.1, data not shown). Application of both groups of antagonists 30 min after HFS did not alter the PS amplitude (data not shown, but representative PS amplitude plot is shown in the Fig. 2A and Fig. 4A insets). We also examined the effect of applying MCPG beginning 20 min after cessation of HFS. Application of the antagonist at this time did not alter PS amplitude (data not shown). This observation suggests that blocking mGluR function cannot reverse LTD once it has been established for 10 s of minutes. This finding also indicates that maintained mGluR activation is not likely to be the mechanism underlying maintained expression of LTD at these post-HFS time points.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We have observed that antagonism of group I mGluRs prevents the induction of striatal long-term synaptic depression. In contrast, antagonists of group II mGluRs did not block LTD induction, but these antagonists were able to prevent acute synaptic depression produced by application of a group II mGluR agonist. Thus the lack of effect of this group II antagonist is not due to the inability of the compound to block striatal mGluRs in the slice preparation. Our results are most consistent with the idea that group I mGluRs play a crucial role in the induction of striatal LTD.
Our findings confirm and extend the previous work of
Calabresi et al. (1992), who observed that the
mGluR antagonist, 2-amino-3-phosphonopropionic acid significantly
reduced corticostriatal LTD, suggesting that mGluR activation is
required for long-term changes in synaptic transmission in the
striatum. There is ample evidence for the expression of both pre- and
postsynaptic mGluRs in the striatum (Calabresi et al.
1993
; Lovinger and McCool 1995
; Testa et
al. 1998
). Testa et al. (1998)
reported that
group I mGluRs and group II mGluRs have distinct cellular localizations
in different components of the basal ganglia. These investigators
suggested that group I mGluRs appear to be postsynaptic receptors
present on the dendrites of striatal medium spiny neurons, and also
suggest the presence of group II mGluRs on the terminals of
corticostriatal afferents, where they may regulate glutamate release.
Our observations, both past and present, agree with this anatomical
distribution of mGluRs. Several group II mGluR agonists produce a
transient depression of glutamatergic transmission that appears to
involve a decrease in presynaptic glutamate release (Lovinger
and McCool 1995
). In contrast, group I agonists such as DHPG,
do not produce presynaptic depression when applied to striatal slices.
However, the antagonist data in the present study indicates that group
I mGluRs do have important roles in long-lasting depression of striatal
synaptic transmission and that group II mGluRs do not participate in
this form of synaptic plasticity. These anatomical and functional data support the idea that mGluRs have an important role in synaptic transmission and synaptic plasiticity through distinct receptor subtypes in the striatum.
A publication that appeared after submission of the present paper also
presented evidence for a crucial role of group I mGluRs in striatal LTD
induction (Gubellini et al. 2001). For the most part,
our findings agree quite well with this report, especially with respect
to the important role of mGluR1 in LTD. However, while we found that
MPEP blocked LTD induction, Gubellini et al. (2001)
did
not observe any effect of MPEP. The reason for this discrepancy is
unclear. However, the difference may relate to the age of the animals
used in the two studies. We have used animals in the postnatal 15-25
day range, a time when striatal LTD is quite robust, while fully adult
rats were used by Gubellini and coworkers. It will be interesting to
determine if changes in the functional role of mGluR5 take place as a
consequence of early postnatal development. Interestingly, both mGluR1
and -5 contribute to activation of striatal cholinergic interneurons
(Pisani et al. 2001
). Thus it is possible that one or
both of these group I mGluRs might contribute to LTD via alterations in
cholinergic synaptic transmission.
Several postsynaptic mechanisms are required for induction of striatal
LTD. Among these mechanisms are depolarization and increased
intracellular calcium in the medium spiny neurons (Calabresi et
al. 1992). The postsynaptically localized group I mGluRs are well positioned to contribute to these important LTD induction mechanisms. Indeed, recent studies from Calabresi and coworkers suggest
that activation of group I mGluRs on medium spiny neurons enhances
increases in intracellular calcium (Pisani et al. 2000
).
It is well known that glutamate can stimulate PI hydrolysis in the
brain, mainly through activation of group I mGluRs
(Knöpfel et al. 1995; Pin and Duvoisin
1995
; Riedel and Reymann 1996
; Schoepp et
al. 1999
). Casabona et al. (1997)
reported
expression and coupling to polyphosphoinositide hydrolysis of group I
mGluRs in several brain areas including striatum. Increased
intracellular Ca2+ concentration resulting from
signaling mechanisms initiated by mGluR activation and PI has been
suggested to be an important mediator of the induction of synaptic
plasticity in the hippocampus (Anwyl 1999
). Previous
reports indicated that application of calcium chelators in the
intracellular solution prevents the induction of corticostriatal LTD
(Calabresi et al. 1992
; Choi and Lovinger 1997a
,b
). These results suggest that increased intracellular
Ca2+ concentration in the postsynaptic neuron is
one essential factor for the induction of LTD in the striatum. Thus it
is quite probable that group I mGluRs act through PI hydrolysis and
increased intracellular Ca2+ to contribute to the
induction of striatal LTD.
It is difficult to determine which of the two group I mGluRs (mGluR1 or
5) has a more important role in striatal LTD induction based on the
present findings. The antagonist 4-CPG has actions on mGluR1a but is
not specific for this receptor type, having either weak agonist
(Hayashi et al. 1994) or weak antagonist (Thomsen et al. 1994
) actions at mGluR2. AIDA has been reported to
selectively antagonize rat mGluR1a compared with mGluR5a and mGluR2
(Moroni et al. 1997
; Pellicciari et al.
1995
). The observation that CPCCOEt blocks LTD induction is
certainly consistent with the idea that mGluR1 is involved in this
process. However, MPEP, at a concentration that appears to be selective
for mGluR5 among the mGluRs, also blocked induction of striatal LTD.
These results are unexpected because MPEP has a selectivity for mGluR5
that is not seen with the other antagonists we used. We do not believe
that MPEP blockade of striatal LTD involves inhibition of NMDA
receptors because it has been clearly demonstrated that striatal LTD is
not blocked by specific NMDA receptor antagonists (Calabresi et
al. 1992
; Choi and Lovinger 1997b
). It is not
clear why more than one type of group I mGluR would need to be involved
in corticostriatal LTD. However, it is tempting to speculate that both
mGluR1 and 5 must be activated for LTD induction to occur. This is not
unreasonable because both of these receptors are present at
glutamatergic synapses on medium spiny neurons (Standaert et al.
1999
; Testa et al. 1998
). Perhaps the two
receptors act in concert to promote increases in intracellular calcium
in the medium spiny neuron during high-frequency activation of
glutamatergic synapses with neither receptor on its own producing
calcium rises of a magnitude sufficient to exceed a threshold needed
for LTD induction. Another potential explanation for our findings is
that a novel group I-like mGluR sensitive to both antagonists is
present in striatum and participates in LTD induction. However, no such
receptor has been identified to date. Despite the fact that we were not
able to implicate only one mGluR subtype in striatal LTD induction, our
results do strongly indicate that the mGluR involved in LTD has the
pharmacological features of a group I receptor based on the relative
specificities of the antagonists used.
It should be noted that none of the four group I antagonists reduced synaptic responses produced by low-frequency afferent stimulation either before or after induction of LTD. This finding suggests that group I mGluRs do not play a prominent role in the induction of synaptic responses during low-frequency afferent input. Furthermore, application of the group I mGluR agonist DHPG did not induce a change in synaptic responses, indicating that activation of group I mGluRs is not sufficient to produce striatal LTD. Rather, these receptors likely act in concert with other proteins, such as dopamine receptors and L-type voltage-gated calcium channels, to initiate the mechanisms required for LTD induction.
In conclusion, the present data show that group I mGluRs are involved in the induction of striatal LTD. In contrast, transmission at these synapses is strongly modulated on an acute time scale by group II mGluRs.
![]() |
ACKNOWLEDGMENTS |
---|
We thank O. Lee for excellent technical assistance.
This study was supported by National Institute of Neurological Disorders and Stroke Grants NS-30470 and NS-37615, by a Korea Science and Engineering Foundation grant to K.-W. Sung, by Korean Ministry of Science and Technology Grant M1-0108-00-0051 under the neurobiology research program to S. Choi, and by Ministry of Science and Technology Grant 00-B-WB-06-A-05 through the National Research and Development program for women's universities to S. Choi.
![]() |
FOOTNOTES |
---|
Address for reprint requests: D. M. Lovinger, Dept. of Molecular Physiology and Biophysics, Vanderbilt University Medical School, 702 Light Hall, Nashville, TN 37232-0615 (E-mail: david.lovinger{at}mcmail.vanderbilt.edu).
Received 21 December 2000; accepted in final form 31 July 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|